(3)
LOS ANGELES, CA and DESERT HOT SPIRNGS, CA / ACCESSWIRE / January 13, 2021 / Grapefruit USA, Inc., (OTCQB:GPFT) ( Grapefruit or the Company ) a premiere fully licensed California based cannabis company, is updating and clarifying recent developments concerning its patented breakthrough, disruptive Hourglass time release THC+ Cannabinoid delivery cream. Grapefruit initially entered into an Exclusive License and Supply Agreement with Zylö Therapeutics Inc., of Greenville, S.C. on July 27, 2020. Execution of this agreement marked the successful completion of the seventeen-month development of Hourglass, the only topical delivery technology capable of efficaciously crossing the transdermal barrier. The Exclusive License and Supply Agreement cemented the Company s relationship with Zylö and provided Grapefruit with the solid intellectual property foundation upon which to build its time release topical cream based THC/cannabinoid medicinal and recreational cannabis business in eve